8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate (TMB-8) acts as a muscarinic receptor antagonist in the epithelial cell line HT29

Naunyn Schmiedebergs Arch Pharmacol. 1996 Feb;353(3):295-301. doi: 10.1007/BF00168631.

Abstract

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) is a widely used pharmacological tool to investigate the involvement of intracellular Ca2+ stores in cellular responses. In this study we investigate the effect of TMB-8 as a putative inhibitor of "Ca2+ signalling" in single fura-2 loaded HT29 colonic epithelial cells stimulated by ATP, carbachol (CCH) and neurotensin (NT). TMB-8 effectively inhibited the CCH-induced (100 mumol/l intracellular Ca2+ ([Ca2+]i) transient with an IC50 of 20 mumol/l. However, [Ca2+]i transients induced by other phospholipase C coupled agonists ATP (10 mumol/l, n = 4) and NT (10 nmol/l, n = 4) remained unaffected by TMB-8 (50 mumol/l). The agonist-induced [Ca2+]i transients remained equally unaffected by 100 mumol/l TMB-8 when the stimulatory concentration was reduced to 0.5 mumol/l for ATP (n = 4) or 1 nmol/l for NT (n = 4). The competitive nature of the TMB-8-induced inhibition of the CCH-induced [Ca2+]i transient was demonstrated by examining the agonist at various concentrations in absence and presence of the antagonist. High TMB-8 concentrations (100 mumol/l) alone induced a small [Ca2+]i increase (delta[Ca2+]i: 40 +/- 5 nmol/l, n = 7). We assume that this increase is a consequence of a TMB-8 induced intracellular alkalinization (delta pH: 0.1 +/- 0.02, n = 7) occurring simultaneously with the increase in [Ca2+]i. From these results we draw the following conclusions: (1) In sharp contrast to a large number of other studies, but in agreement with studies in other types of cells, these results substantially challenge the value of the "tool" TMB-8 as an "intracellular Ca2+ antagonist"; (2) TMB-8 acts a muscarinic receptor antagonist at the M3 receptor; (3) TMB-8 does not influence the release of Ca2+ from intracellular stores when IP3 signal transduction is activated by ATP or NT; (4) TMB-8 as a weak organic base alkalinizes the cytosol at high concentrations; and (5) TMB-8 induces small [Ca2+]i transients at higher concentrations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Binding, Competitive
  • Calcium / metabolism
  • Calcium Channel Blockers / metabolism
  • Calcium Channel Blockers / pharmacology*
  • Carbachol / pharmacology
  • Colon / cytology
  • Colon / drug effects*
  • Colon / metabolism
  • Dose-Response Relationship, Drug
  • Epithelial Cells
  • Epithelium / drug effects
  • Epithelium / metabolism
  • Fura-2 / chemistry
  • Gallic Acid / analogs & derivatives*
  • Gallic Acid / metabolism
  • Gallic Acid / pharmacology
  • HT29 Cells
  • Humans
  • Muscarinic Antagonists / metabolism
  • Muscarinic Antagonists / pharmacology*
  • Neurotensin / pharmacology
  • Type C Phospholipases / metabolism

Substances

  • Calcium Channel Blockers
  • Muscarinic Antagonists
  • Neurotensin
  • 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
  • Gallic Acid
  • Adenosine Triphosphate
  • Carbachol
  • Type C Phospholipases
  • Calcium
  • Fura-2